APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs of UDCA and t-UDCA

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drugs of UDCA and t-UDCA Market Analysis and Forecast 2026-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchDrugs of UDCA and t-UDCA Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs of UDCA and t-UDCA Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Drugs of UDCA and t-UDCA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs of UDCA and t-UDCA Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs of UDCA and t-UDCA Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drugs of UDCA and t-UDCA market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Drugs of UDCA and t-UDCA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drugs of UDCA and t-UDCA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drugs of UDCA and t-UDCA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drugs of UDCA and t-UDCA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Drugs of UDCA and t-UDCA include Bruschettini, Daewoong Pharmaceutical, Dr. Falk Pharma, Epic Pharma, Grindeks, Impax, Lannett, Mitsubishi Tanabe Pharma and Viatris, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Drugs of UDCA and t-UDCA, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drugs of UDCA and t-UDCA, also provides the sales of main regions and countries. Of the upcoming market potential for Drugs of UDCA and t-UDCA, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs of UDCA and t-UDCA sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drugs of UDCA and t-UDCA market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Drugs of UDCA and t-UDCA sales, projected growth trends, production technology, application and end-user industry.

Drugs of UDCA and t-UDCA Segment by Company

Bruschettini

Daewoong Pharmaceutical

Dr. Falk Pharma

Epic Pharma

Grindeks

Impax

Lannett

Mitsubishi Tanabe Pharma

Viatris

Shanghai Pharma

Teva

Drugs of UDCA and t-UDCA Segment by Type

t-UDCA

UDCA

Drugs of UDCA and t-UDCA Segment by Application

Hepatopathy

Gallstone

Biliary Disease

Other

Drugs of UDCA and t-UDCA Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of UDCA and t-UDCA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs of UDCA and t-UDCA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of UDCA and t-UDCA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Drugs of UDCA and t-UDCA in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Drugs of UDCA and t-UDCA manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs of UDCA and t-UDCA sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs of UDCA and t-UDCA Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. t-UDCA Major Manufacturers Table 3. UDCA Major Manufacturers Table 4. Global Drugs of UDCA and t-UDCA Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hepatopathy Major Manufacturers Table 6. Gallstone Major Manufacturers Table 7. Biliary Disease Major Manufacturers Table 8. Other Major Manufacturers Table 9. Drugs of UDCA and t-UDCA Industry Trends Table 10. Drugs of UDCA and t-UDCA Industry Drivers Table 11. Drugs of UDCA and t-UDCA Industry Opportunities and Challenges Table 12. Drugs of UDCA and t-UDCA Industry Restraints Table 13. Global Drugs of UDCA and t-UDCA Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Drugs of UDCA and t-UDCA Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Drugs of UDCA and t-UDCA Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region (2021-2026) Table 17. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region (2027-2032) Table 18. Global Drugs of UDCA and t-UDCA Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Drugs of UDCA and t-UDCA Sales by Region (2021-2026) & (K Units) Table 20. Global Drugs of UDCA and t-UDCA Sales by Region (2027-2032) & (K Units) Table 21. Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2021-2026) Table 22. Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2027-2032) Table 23. Global Drugs of UDCA and t-UDCA Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Drugs of UDCA and t-UDCA Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Drugs of UDCA and t-UDCA Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Drugs of UDCA and t-UDCA Sales Market Share by Manufacturers (2021-2026) Table 27. Global Drugs of UDCA and t-UDCA Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Drugs of UDCA and t-UDCA Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Drugs of UDCA and t-UDCA Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Drugs of UDCA and t-UDCA Manufacturers, Product Type & Application Table 31. Global Drugs of UDCA and t-UDCA Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Drugs of UDCA and t-UDCA by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Drugs of UDCA and t-UDCA Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Drugs of UDCA and t-UDCA Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Drugs of UDCA and t-UDCA Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Drugs of UDCA and t-UDCA Revenue Market Share by Type (2021-2026) Table 38. Global Drugs of UDCA and t-UDCA Revenue Market Share by Type (2027-2032) Table 39. Global Drugs of UDCA and t-UDCA Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 41. Global Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (K Units) Table 42. Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2021-2026) Table 43. Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2027-2032) Table 44. Global Drugs of UDCA and t-UDCA Price by Type (2021-2026) & (US$/Unit) Table 45. Global Drugs of UDCA and t-UDCA Price by Type (2027-2032) & (US$/Unit) Table 46. Global Drugs of UDCA and t-UDCA Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Drugs of UDCA and t-UDCA Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Drugs of UDCA and t-UDCA Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Drugs of UDCA and t-UDCA Revenue Market Share by Application (2021-2026) Table 50. Global Drugs of UDCA and t-UDCA Revenue Market Share by Application (2027-2032) Table 51. Global Drugs of UDCA and t-UDCA Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 53. Global Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (K Units) Table 54. Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2021-2026) Table 55. Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2027-2032) Table 56. Global Drugs of UDCA and t-UDCA Price by Application (2021-2026) & (US$/Unit) Table 57. Global Drugs of UDCA and t-UDCA Price by Application (2027-2032) & (US$/Unit) Table 58. Bruschettini Company Information Table 59. Bruschettini Business Overview Table 60. Bruschettini Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Bruschettini Drugs of UDCA and t-UDCA Product Portfolio Table 62. Bruschettini Recent Development Table 63. Daewoong Pharmaceutical Company Information Table 64. Daewoong Pharmaceutical Business Overview Table 65. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product Portfolio Table 67. Daewoong Pharmaceutical Recent Development Table 68. Dr. Falk Pharma Company Information Table 69. Dr. Falk Pharma Business Overview Table 70. Dr. Falk Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Dr. Falk Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 72. Dr. Falk Pharma Recent Development Table 73. Epic Pharma Company Information Table 74. Epic Pharma Business Overview Table 75. Epic Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Epic Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 77. Epic Pharma Recent Development Table 78. Grindeks Company Information Table 79. Grindeks Business Overview Table 80. Grindeks Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Grindeks Drugs of UDCA and t-UDCA Product Portfolio Table 82. Grindeks Recent Development Table 83. Impax Company Information Table 84. Impax Business Overview Table 85. Impax Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Impax Drugs of UDCA and t-UDCA Product Portfolio Table 87. Impax Recent Development Table 88. Lannett Company Information Table 89. Lannett Business Overview Table 90. Lannett Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Lannett Drugs of UDCA and t-UDCA Product Portfolio Table 92. Lannett Recent Development Table 93. Mitsubishi Tanabe Pharma Company Information Table 94. Mitsubishi Tanabe Pharma Business Overview Table 95. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 97. Mitsubishi Tanabe Pharma Recent Development Table 98. Viatris Company Information Table 99. Viatris Business Overview Table 100. Viatris Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Viatris Drugs of UDCA and t-UDCA Product Portfolio Table 102. Viatris Recent Development Table 103. Shanghai Pharma Company Information Table 104. Shanghai Pharma Business Overview Table 105. Shanghai Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Shanghai Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 107. Shanghai Pharma Recent Development Table 108. Teva Company Information Table 109. Teva Business Overview Table 110. Teva Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Teva Drugs of UDCA and t-UDCA Product Portfolio Table 112. Teva Recent Development Table 113. North America Drugs of UDCA and t-UDCA Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Drugs of UDCA and t-UDCA Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 116. North America Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (K Units) Table 117. North America Drugs of UDCA and t-UDCA Sales Price by Type (2021-2026) & (US$/Unit) Table 118. North America Drugs of UDCA and t-UDCA Sales Price by Type (2027-2032) & (US$/Unit) Table 119. North America Drugs of UDCA and t-UDCA Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Drugs of UDCA and t-UDCA Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 122. North America Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (K Units) Table 123. North America Drugs of UDCA and t-UDCA Sales Price by Application (2021-2026) & (US$/Unit) Table 124. North America Drugs of UDCA and t-UDCA Sales Price by Application (2027-2032) & (US$/Unit) Table 125. North America Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 129. North America Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 130. North America Drugs of UDCA and t-UDCA Sales by Country (2027-2032) & (K Units) Table 131. North America Drugs of UDCA and t-UDCA Sales Price by Country (2021-2026) & (US$/Unit) Table 132. North America Drugs of UDCA and t-UDCA Sales Price by Country (2027-2032) & (US$/Unit) Table 133. United States Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 134. Canada Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 135. Europe Drugs of UDCA and t-UDCA Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Drugs of UDCA and t-UDCA Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 138. Europe Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (K Units) Table 139. Europe Drugs of UDCA and t-UDCA Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Europe Drugs of UDCA and t-UDCA Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Europe Drugs of UDCA and t-UDCA Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Drugs of UDCA and t-UDCA Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 144. Europe Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (K Units) Table 145. Europe Drugs of UDCA and t-UDCA Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Europe Drugs of UDCA and t-UDCA Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Europe Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Europe Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 152. Europe Drugs of UDCA and t-UDCA Sales by Country (2027-2032) & (K Units) Table 153. Europe Drugs of UDCA and t-UDCA Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Europe Drugs of UDCA and t-UDCA Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Germany Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 156. France Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 157. U.K. Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 158. Italy Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 159. Netherlands Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 160. China Drugs of UDCA and t-UDCA Revenue by Type (2021-2026) & (US$ Million) Table 161. China Drugs of UDCA and t-UDCA Revenue by Type (2027-2032) & (US$ Million) Table 162. China Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 163. China Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (K Units) Table 164. China Drugs of UDCA and t-UDCA Sales Price by Type (2021-2026) & (US$/Unit) Table 165. China Drugs of UDCA and t-UDCA Sales Price by Type (2027-2032) & (US$/Unit) Table 166. China Drugs of UDCA and t-UDCA Revenue by Application (2021-2026) & (US$ Million) Table 167. China Drugs of UDCA and t-UDCA Revenue by Application (2027-2032) & (US$ Million) Table 168. China Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 169. China Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (K Units) Table 170. China Drugs of UDCA and t-UDCA Sales Price by Application (2021-2026) & (US$/Unit) Table 171. China Drugs of UDCA and t-UDCA Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Drugs of UDCA and t-UDCA Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Drugs of UDCA and t-UDCA Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 175. Asia Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (K Units) Table 176. Asia Drugs of UDCA and t-UDCA Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Asia Drugs of UDCA and t-UDCA Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Asia Drugs of UDCA and t-UDCA Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Drugs of UDCA and t-UDCA Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 181. Asia Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (K Units) Table 182. Asia Drugs of UDCA and t-UDCA Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Asia Drugs of UDCA and t-UDCA Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Asia Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Asia Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 189. Asia Drugs of UDCA and t-UDCA Sales by Country (2027-2032) & (K Units) Table 190. Asia Drugs of UDCA and t-UDCA Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Asia Drugs of UDCA and t-UDCA Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Japan Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 193. South Korea Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 194. India Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 195. Australia Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 196. China Taiwan Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Drugs of UDCA and t-UDCA Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Drugs of UDCA and t-UDCA Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 201. SAMEA Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (K Units) Table 202. SAMEA Drugs of UDCA and t-UDCA Sales Price by Type (2021-2026) & (US$/Unit) Table 203. SAMEA Drugs of UDCA and t-UDCA Sales Price by Type (2027-2032) & (US$/Unit) Table 204. SAMEA Drugs of UDCA and t-UDCA Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Drugs of UDCA and t-UDCA Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 207. SAMEA Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (K Units) Table 208. SAMEA Drugs of UDCA and t-UDCA Sales Price by Application (2021-2026) & (US$/Unit) Table 209. SAMEA Drugs of UDCA and t-UDCA Sales Price by Application (2027-2032) & (US$/Unit) Table 210. SAMEA Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 214. SAMEA Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 215. SAMEA Drugs of UDCA and t-UDCA Sales by Country (2027-2032) & (K Units) Table 216. SAMEA Drugs of UDCA and t-UDCA Sales Price by Country (2021-2026) & (US$/Unit) Table 217. SAMEA Drugs of UDCA and t-UDCA Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Brazil Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 219. Argentina Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 220. Chile Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 221. Colombia Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 222. Peru Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 224. Israel Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 225. UAE Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 226. Turkey Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 227. Iran Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 228. Egypt Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Drugs of UDCA and t-UDCA Distributors List Table 232. Drugs of UDCA and t-UDCA Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Drugs of UDCA and t-UDCA Image Figure 2. Global Drugs of UDCA and t-UDCA Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs of UDCA and t-UDCA Market Size Share 2021 VS 2025 VS 2032 Figure 4. t-UDCA Image Figure 5. UDCA Image Figure 6. Global Drugs of UDCA and t-UDCA Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Drugs of UDCA and t-UDCA Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hepatopathy Image Figure 9. Gallstone Image Figure 10. Biliary Disease Image Figure 11. Other Image Figure 12. Global Drugs of UDCA and t-UDCA Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Drugs of UDCA and t-UDCA Revenue (2021-2032) & (US$ Million) Figure 14. Global Drugs of UDCA and t-UDCA Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region (2021-2032) Figure 17. Global Drugs of UDCA and t-UDCA Sales (2021-2032) & (K Units) Figure 18. Global Drugs of UDCA and t-UDCA Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Drugs of UDCA and t-UDCA Sales YoY (2021-2032) & (K Units) Figure 21. Europe Drugs of UDCA and t-UDCA Sales YoY (2021-2032) & (K Units) Figure 22. China Drugs of UDCA and t-UDCA Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Drugs of UDCA and t-UDCA Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Drugs of UDCA and t-UDCA Sales YoY (2021-2032) & (K Units) Figure 25. Global Drugs of UDCA and t-UDCA Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Drugs of UDCA and t-UDCA Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Drugs of UDCA and t-UDCA Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Drugs of UDCA and t-UDCA Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Drugs of UDCA and t-UDCA Revenue Market Share by Type (2021-2032) Figure 31. Global Drugs of UDCA and t-UDCA Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Drugs of UDCA and t-UDCA Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2021-2032) Figure 34. Global Drugs of UDCA and t-UDCA Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Drugs of UDCA and t-UDCA Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Drugs of UDCA and t-UDCA Revenue Market Share by Application (2021-2032) Figure 37. Global Drugs of UDCA and t-UDCA Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Drugs of UDCA and t-UDCA Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2021-2032) Figure 40. North America Drugs of UDCA and t-UDCA Revenue Share by Type (2021-2032) Figure 41. North America Drugs of UDCA and t-UDCA Sales Share by Type (2021-2032) Figure 42. North America Drugs of UDCA and t-UDCA Revenue Share by Application (2021-2032) Figure 43. North America Drugs of UDCA and t-UDCA Sales Share by Application (2021-2032) Figure 44. North America Drugs of UDCA and t-UDCA Revenue Share by Country (2021-2032) Figure 45. North America Drugs of UDCA and t-UDCA Sales Share by Country (2021-2032) Figure 46. Europe Drugs of UDCA and t-UDCA Revenue Share by Type (2021-2032) Figure 47. Europe Drugs of UDCA and t-UDCA Sales Share by Type (2021-2032) Figure 48. Europe Drugs of UDCA and t-UDCA Revenue Share by Application (2021-2032) Figure 49. Europe Drugs of UDCA and t-UDCA Sales Share by Application (2021-2032) Figure 50. Europe Drugs of UDCA and t-UDCA Revenue Share by Country (2021-2032) Figure 51. Europe Drugs of UDCA and t-UDCA Sales Share by Country (2021-2032) Figure 52. China Drugs of UDCA and t-UDCA Revenue Share by Type (2021-2032) Figure 53. China Drugs of UDCA and t-UDCA Sales Share by Type (2021-2032) Figure 54. China Drugs of UDCA and t-UDCA Revenue Share by Application (2021-2032) Figure 55. China Drugs of UDCA and t-UDCA Sales Share by Application (2021-2032) Figure 56. Asia Drugs of UDCA and t-UDCA Revenue Share by Type (2021-2032) Figure 57. Asia Drugs of UDCA and t-UDCA Sales Share by Type (2021-2032) Figure 58. Asia Drugs of UDCA and t-UDCA Revenue Share by Application (2021-2032) Figure 59. Asia Drugs of UDCA and t-UDCA Sales Share by Application (2021-2032) Figure 60. Asia Drugs of UDCA and t-UDCA Revenue Share by Country (2021-2032) Figure 61. Asia Drugs of UDCA and t-UDCA Sales Share by Country (2021-2032) Figure 62. SAMEA Drugs of UDCA and t-UDCA Revenue Share by Type (2021-2032) Figure 63. SAMEA Drugs of UDCA and t-UDCA Sales Share by Type (2021-2032) Figure 64. SAMEA Drugs of UDCA and t-UDCA Revenue Share by Application (2021-2032) Figure 65. SAMEA Drugs of UDCA and t-UDCA Sales Share by Application (2021-2032) Figure 66. SAMEA Drugs of UDCA and t-UDCA Revenue Share by Country (2021-2032) Figure 67. SAMEA Drugs of UDCA and t-UDCA Sales Share by Country (2021-2032) Figure 68. Drugs of UDCA and t-UDCA Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Drugs of UDCA and t-UDCA Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • t-UDCA
  • UDCA
Applications
  • Hepatopathy
  • Gallstone
  • Biliary Disease
  • Other
Companies covered
  • Bruschettini
  • Daewoong Pharmaceutical
  • Dr. Falk Pharma
  • Epic Pharma
  • Grindeks
  • Impax
  • Lannett
  • Mitsubishi Tanabe Pharma
  • Viatris
  • Shanghai Pharma
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drugs of UDCA and t-UDCA Market by Type
  3. 1.2.1 Global Drugs of UDCA and t-UDCA Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 t-UDCA
  5. 1.2.3 UDCA
  6. 1.3 Drugs of UDCA and t-UDCA Market by Application
  7. 1.3.1 Global Drugs of UDCA and t-UDCA Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hepatopathy
  9. 1.3.3 Gallstone
  10. 1.3.4 Biliary Disease
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Drugs of UDCA and t-UDCA Market Dynamics
  1. 2.1 Drugs of UDCA and t-UDCA Industry Trends
  2. 2.2 Drugs of UDCA and t-UDCA Industry Drivers
  3. 2.3 Drugs of UDCA and t-UDCA Industry Opportunities and Challenges
  4. 2.4 Drugs of UDCA and t-UDCA Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Drugs of UDCA and t-UDCA Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Drugs of UDCA and t-UDCA Revenue by Region
  3. 3.2.1 Global Drugs of UDCA and t-UDCA Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drugs of UDCA and t-UDCA Revenue by Region (2021-2026)
  5. 3.2.3 Global Drugs of UDCA and t-UDCA Revenue by Region (2027-2032)
  6. 3.2.4 Global Drugs of UDCA and t-UDCA Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Drugs of UDCA and t-UDCA Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Drugs of UDCA and t-UDCA Sales by Region
  9. 3.4.1 Global Drugs of UDCA and t-UDCA Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Drugs of UDCA and t-UDCA Sales by Region (2021-2026)
  11. 3.4.3 Global Drugs of UDCA and t-UDCA Sales by Region (2027-2032)
  12. 3.4.4 Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Drugs of UDCA and t-UDCA Revenue by Manufacturers
  2. 4.1.1 Global Drugs of UDCA and t-UDCA Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Drugs of UDCA and t-UDCA Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Drugs of UDCA and t-UDCA Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drugs of UDCA and t-UDCA Sales by Manufacturers
  6. 4.2.1 Global Drugs of UDCA and t-UDCA Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Drugs of UDCA and t-UDCA Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Drugs of UDCA and t-UDCA Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Drugs of UDCA and t-UDCA Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Drugs of UDCA and t-UDCA Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Drugs of UDCA and t-UDCA Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Drugs of UDCA and t-UDCA Manufacturers, Product Type & Application
  13. 4.7 Global Drugs of UDCA and t-UDCA Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Drugs of UDCA and t-UDCA Market CR5 and HHI
  16. 4.8.2 2025 Drugs of UDCA and t-UDCA Tier 1, Tier 2, and Tier 3
5 Drugs of UDCA and t-UDCA Market by Type
  1. 5.1 Global Drugs of UDCA and t-UDCA Revenue by Type
  2. 5.1.1 Global Drugs of UDCA and t-UDCA Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Drugs of UDCA and t-UDCA Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Drugs of UDCA and t-UDCA Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Drugs of UDCA and t-UDCA Sales by Type
  6. 5.2.1 Global Drugs of UDCA and t-UDCA Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drugs of UDCA and t-UDCA Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2021-2032)
  9. 5.3 Global Drugs of UDCA and t-UDCA Price by Type
6 Drugs of UDCA and t-UDCA Market by Application
  1. 6.1 Global Drugs of UDCA and t-UDCA Revenue by Application
  2. 6.1.1 Global Drugs of UDCA and t-UDCA Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Drugs of UDCA and t-UDCA Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Drugs of UDCA and t-UDCA Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Drugs of UDCA and t-UDCA Sales by Application
  6. 6.2.1 Global Drugs of UDCA and t-UDCA Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Drugs of UDCA and t-UDCA Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2021-2032)
  9. 6.3 Global Drugs of UDCA and t-UDCA Price by Application
7 Company Profiles
  1. 7.1 Bruschettini
  2. 7.1.1 Bruschettini Company Information
  3. 7.1.2 Bruschettini Business Overview
  4. 7.1.3 Bruschettini Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bruschettini Drugs of UDCA and t-UDCA Product Portfolio
  6. 7.1.5 Bruschettini Recent Developments
  7. 7.2 Daewoong Pharmaceutical
  8. 7.2.1 Daewoong Pharmaceutical Company Information
  9. 7.2.2 Daewoong Pharmaceutical Business Overview
  10. 7.2.3 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product Portfolio
  12. 7.2.5 Daewoong Pharmaceutical Recent Developments
  13. 7.3 Dr. Falk Pharma
  14. 7.3.1 Dr. Falk Pharma Company Information
  15. 7.3.2 Dr. Falk Pharma Business Overview
  16. 7.3.3 Dr. Falk Pharma Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Dr. Falk Pharma Drugs of UDCA and t-UDCA Product Portfolio
  18. 7.3.5 Dr. Falk Pharma Recent Developments
  19. 7.4 Epic Pharma
  20. 7.4.1 Epic Pharma Company Information
  21. 7.4.2 Epic Pharma Business Overview
  22. 7.4.3 Epic Pharma Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Epic Pharma Drugs of UDCA and t-UDCA Product Portfolio
  24. 7.4.5 Epic Pharma Recent Developments
  25. 7.5 Grindeks
  26. 7.5.1 Grindeks Company Information
  27. 7.5.2 Grindeks Business Overview
  28. 7.5.3 Grindeks Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Grindeks Drugs of UDCA and t-UDCA Product Portfolio
  30. 7.5.5 Grindeks Recent Developments
  31. 7.6 Impax
  32. 7.6.1 Impax Company Information
  33. 7.6.2 Impax Business Overview
  34. 7.6.3 Impax Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Impax Drugs of UDCA and t-UDCA Product Portfolio
  36. 7.6.5 Impax Recent Developments
  37. 7.7 Lannett
  38. 7.7.1 Lannett Company Information
  39. 7.7.2 Lannett Business Overview
  40. 7.7.3 Lannett Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lannett Drugs of UDCA and t-UDCA Product Portfolio
  42. 7.7.5 Lannett Recent Developments
  43. 7.8 Mitsubishi Tanabe Pharma
  44. 7.8.1 Mitsubishi Tanabe Pharma Company Information
  45. 7.8.2 Mitsubishi Tanabe Pharma Business Overview
  46. 7.8.3 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product Portfolio
  48. 7.8.5 Mitsubishi Tanabe Pharma Recent Developments
  49. 7.9 Viatris
  50. 7.9.1 Viatris Company Information
  51. 7.9.2 Viatris Business Overview
  52. 7.9.3 Viatris Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Viatris Drugs of UDCA and t-UDCA Product Portfolio
  54. 7.9.5 Viatris Recent Developments
  55. 7.10 Shanghai Pharma
  56. 7.10.1 Shanghai Pharma Company Information
  57. 7.10.2 Shanghai Pharma Business Overview
  58. 7.10.3 Shanghai Pharma Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shanghai Pharma Drugs of UDCA and t-UDCA Product Portfolio
  60. 7.10.5 Shanghai Pharma Recent Developments
  61. 7.11 Teva
  62. 7.11.1 Teva Company Information
  63. 7.11.2 Teva Business Overview
  64. 7.11.3 Teva Drugs of UDCA and t-UDCA Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Teva Drugs of UDCA and t-UDCA Product Portfolio
  66. 7.11.5 Teva Recent Developments
8 North America
  1. 8.1 North America Drugs of UDCA and t-UDCA Market Size by Type
  2. 8.1.1 North America Drugs of UDCA and t-UDCA Revenue by Type (2021-2032)
  3. 8.1.2 North America Drugs of UDCA and t-UDCA Sales by Type (2021-2032)
  4. 8.1.3 North America Drugs of UDCA and t-UDCA Price by Type (2021-2032)
  5. 8.2 North America Drugs of UDCA and t-UDCA Market Size by Application
  6. 8.2.1 North America Drugs of UDCA and t-UDCA Revenue by Application (2021-2032)
  7. 8.2.2 North America Drugs of UDCA and t-UDCA Sales by Application (2021-2032)
  8. 8.2.3 North America Drugs of UDCA and t-UDCA Price by Application (2021-2032)
  9. 8.3 North America Drugs of UDCA and t-UDCA Market Size by Country
  10. 8.3.1 North America Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Drugs of UDCA and t-UDCA Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Drugs of UDCA and t-UDCA Market Size by Type
  2. 9.1.1 Europe Drugs of UDCA and t-UDCA Revenue by Type (2021-2032)
  3. 9.1.2 Europe Drugs of UDCA and t-UDCA Sales by Type (2021-2032)
  4. 9.1.3 Europe Drugs of UDCA and t-UDCA Price by Type (2021-2032)
  5. 9.2 Europe Drugs of UDCA and t-UDCA Market Size by Application
  6. 9.2.1 Europe Drugs of UDCA and t-UDCA Revenue by Application (2021-2032)
  7. 9.2.2 Europe Drugs of UDCA and t-UDCA Sales by Application (2021-2032)
  8. 9.2.3 Europe Drugs of UDCA and t-UDCA Price by Application (2021-2032)
  9. 9.3 Europe Drugs of UDCA and t-UDCA Market Size by Country
  10. 9.3.1 Europe Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Drugs of UDCA and t-UDCA Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Drugs of UDCA and t-UDCA Market Size by Type
  2. 10.1.1 China Drugs of UDCA and t-UDCA Revenue by Type (2021-2032)
  3. 10.1.2 China Drugs of UDCA and t-UDCA Sales by Type (2021-2032)
  4. 10.1.3 China Drugs of UDCA and t-UDCA Price by Type (2021-2032)
  5. 10.2 China Drugs of UDCA and t-UDCA Market Size by Application
  6. 10.2.1 China Drugs of UDCA and t-UDCA Revenue by Application (2021-2032)
  7. 10.2.2 China Drugs of UDCA and t-UDCA Sales by Application (2021-2032)
  8. 10.2.3 China Drugs of UDCA and t-UDCA Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drugs of UDCA and t-UDCA Market Size by Type
  2. 11.1.1 Asia Drugs of UDCA and t-UDCA Revenue by Type (2021-2032)
  3. 11.1.2 Asia Drugs of UDCA and t-UDCA Sales by Type (2021-2032)
  4. 11.1.3 Asia Drugs of UDCA and t-UDCA Price by Type (2021-2032)
  5. 11.2 Asia Drugs of UDCA and t-UDCA Market Size by Application
  6. 11.2.1 Asia Drugs of UDCA and t-UDCA Revenue by Application (2021-2032)
  7. 11.2.2 Asia Drugs of UDCA and t-UDCA Sales by Application (2021-2032)
  8. 11.2.3 Asia Drugs of UDCA and t-UDCA Price by Application (2021-2032)
  9. 11.3 Asia Drugs of UDCA and t-UDCA Market Size by Country
  10. 11.3.1 Asia Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Drugs of UDCA and t-UDCA Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drugs of UDCA and t-UDCA Market Size by Type
  2. 12.1.1 SAMEA Drugs of UDCA and t-UDCA Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Drugs of UDCA and t-UDCA Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Drugs of UDCA and t-UDCA Price by Type (2021-2032)
  5. 12.2 SAMEA Drugs of UDCA and t-UDCA Market Size by Application
  6. 12.2.1 SAMEA Drugs of UDCA and t-UDCA Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Drugs of UDCA and t-UDCA Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Drugs of UDCA and t-UDCA Price by Application (2021-2032)
  9. 12.3 SAMEA Drugs of UDCA and t-UDCA Market Size by Country
  10. 12.3.1 SAMEA Drugs of UDCA and t-UDCA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Drugs of UDCA and t-UDCA Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Drugs of UDCA and t-UDCA Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Drugs of UDCA and t-UDCA Value Chain Analysis
  2. 13.1.1 Drugs of UDCA and t-UDCA Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Drugs of UDCA and t-UDCA Production Mode & Process
  6. 13.2 Drugs of UDCA and t-UDCA Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Drugs of UDCA and t-UDCA Distributors
  9. 13.2.3 Drugs of UDCA and t-UDCA Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst